WCN24-1265 THE SAFETY OF SYSTEMIC ANTICANCER TREATMENT IN PATIENTS WITH END-STAGE KIDNEY DISEASE AND METASTATIC RENAL CELL CARCINOMA

• Tomaz Milanez,
• Miha Arnol,
• Bostjan Seruga,
• Vinay Srinivasan,
• Janja Ocvirk,
• Edgar A. Jaimes

Affiliations

Tomaz Milanez

Ljubljana, Devision of Medical Oncology, Department of Nephro, Slovenia

Miha Arnol

Department of Nephrology, University Medical Center Ljubljana, Ljubljana

Bostjan Seruga

Devision of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana

Vinay Srinivasan

Division of Nephrology, Cooper University Hospital and Cooper Medical School of Rowan University Camden, New Jersey, USA, Ljubljana

Janja Ocvirk

Devision of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana

Edgar A. Jaimes

Renal Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medicine, New York, NY, New York